Silo Pharma annual gross margin
2019
2020
2022
2023
2024
2025
Silo Pharma's gross margin was 38.57% for fiscal 2025.
View full Silo Pharma company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 38.57% | −53.34 pp |
| 2024 | 2024-12-31 | 91.90% | 0.00 pp |
| 2023 | 2023-12-31 | 91.90% | 0.00 pp |
| 2022 | 2022-12-31 | 91.90% | +422.29 pp |
| 2020 | 2020-12-31 | −330.38% | −362.88 pp |
| 2019 | 2019-12-31 | 32.49% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q1 2026 | 2026-03-31 | −14.77% | −106.67 pp |
| Q4 2025 | 2025-12-31 | −14.77% | −106.67 pp |
| Q3 2025 | 2025-09-30 | −14.77% | −106.67 pp |
| Q2 2025 | 2025-06-30 | 91.91% | 0.00 pp |
| Q1 2025 | 2025-03-31 | 91.90% | 0.00 pp |
| Q4 2024 | 2024-12-31 | 91.90% | 0.00 pp |
| Q3 2024 | 2024-09-30 | 91.91% | 0.00 pp |
| Q2 2024 | 2024-06-30 | 91.91% | 0.00 pp |
| Q1 2024 | 2024-03-31 | 91.90% | 0.00 pp |
| Q4 2023 | 2023-12-31 | 91.90% | −0.01 pp |
| Q3 2023 | 2023-09-30 | 91.91% | 0.00 pp |
| Q2 2023 | 2023-06-30 | 91.91% | +67.57 pp |
| Q1 2023 | 2023-03-31 | 91.90% | +56.98 pp |
| Q3 2022 | 2022-09-30 | 91.91% | +648.36 pp |
| Q2 2022 | 2022-06-30 | 91.91% | +172.74 pp |
| Q2 2021 | 2021-06-30 | 24.33% | −15.52 pp |
| Q1 2021 | 2021-03-31 | 34.92% | −36.51 pp |
| Q4 2020 | 2020-12-31 | −556.45% | −625.86 pp |
| Q3 2020 | 2020-09-30 | −80.84% | — |
| Q2 2020 | 2020-06-30 | 39.85% | — |
| Q1 2020 | 2020-03-31 | 71.43% | — |
| Q3 2019 | 2019-09-30 | 69.40% | — |
Over the last five reported fiscal years, Silo Pharma's gross margin increased from 32.49% to 38.57%, a change of +6.07 percentage points. The latest reported quarter, Q1 2026, shows −14.77%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Silo Pharma filings at SEC.gov ↗